Aug 12, 2020
Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue Catalysts
Aug 06, 2020
European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation
May 21, 2020
Cellect Biotechnology Reports First Quarter 2020 Financial and Operating Results; Continues to Demonstrate Significant Progress Despite Adjusted Operations Due to COVID-19
May 18, 2020
Cellect Biotechnology's ApoGraft(TM) to Empower Cellular Treatment of COVID-19 Related Pulmonary Diseases
Apr 27, 2020
Cellect Biotechnology Continues to Achieve Milestones; Receives New Patent Allowance in Canada
Apr 03, 2020
Cellect Biotechnology Reports Fourth Quarter and Full Year 2019 Results
Apr 02, 2020
Cellect Biotechnology Receives New Patent Allowance in China
Mar 04, 2020
Cellect Biotechnology and Canndoc Ltd. to Enter Into Strategic Pharma Grade Cannabis Commercial Deal for Reduction in Opioid Usage
Jan 08, 2020
Cellect Biotechnology Ltd. Prices $3m Registered Direct Offering of American Depositary Shares
Jan 07, 2020
Cellect Biotechnology Strengthens IP Portfolio; Receives "Intention to Grant" Patents from European and Israeli Patent Offices
Dec 23, 2019
Cellect Biotechnology Receives Approval for U.S. Clinical Trial
Nov 19, 2019
Cellect Biotechnology Reports Third Quarter 2019 Financial and Operating Results
Nov 07, 2019
Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement
Aug 13, 2019
Cellect Biotechnology Reports Second Quarter 2019 Financial and Operating Results
Jul 08, 2019
Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement
May 21, 2019
Cellect Biotechnology Reports First Quarter 2019 Financial and Operating Results
May 06, 2019
Frost & Sullivan Publishes Annual Update on Cellect
Mar 27, 2019
Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft(TM) Technology
Mar 18, 2019
Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress
Mar 11, 2019
Cellect Announces Positive Results From Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem Cells